RRC ID 54895
著者 Takagi Y, Kikuchi T, Niimura M, Ohno T.
タイトル Anti-tumor effects of dendritic and tumor cell fusions are not dependent on expression of MHC class I and II by dendritic cells.
ジャーナル Cancer Lett
Abstract Vaccination of fusion cells (FCs) made from dendritic and tumor cells elicits anti-tumor effects. We investigated whether major histocompatibility complex (MHC) class I and II play an important role in the induction of anti-tumor immunity by FCs. Immunization with fusion cells composed of syngeneic, allogeneic, or MHC I(-/-)II(-/-) DCs and B16 cells inhibited tumor growth. Elispot assay showed a higher population of interferon-gamma secreting T lymphocytes in mice immunized with fusion cells. These data suggest that anti-tumor effects of DCs and tumor cell fusions are not dependent on the expression of MHC class I and II on DCs.
巻・号 213(1)
ページ 49-55
公開日 2004-9-15
DOI 10.1016/j.canlet.2004.04.010
PII S0304383504003179
PMID 15312683
MeSH Animals Cancer Vaccines / immunology* Dendritic Cells / immunology* Female Genes, MHC Class I* Genes, MHC Class II* HLA Antigens / biosynthesis Immunotherapy / methods Melanoma / immunology* Melanoma / pathology Mice Mice, Inbred C57BL Mice, Knockout Neoplasms, Experimental Skin Neoplasms / immunology* Skin Neoplasms / pathology Tumor Cells, Cultured / immunology*
リソース情報
ヒト・動物細胞 B16